Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-747

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 747 52 Master Bottle Label Approval Rev A 07 21)

Label for Atorvastatin Calcium Tablets USP 80 mg oral film-coated tablets, 30 count, prescription only. Manufactured by Northwind Health Company, LLC, the label includes storage instructions, dosage reference, and repackaging information by Ascend Laboratories.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A cumulative incidence line graph comparing Atorvastatin with placebo over approximately 3.5 years. The x-axis represents time in years, and the y-axis shows cumulative incidence percentage. The graph displays two lines: a solid line for Atorvastatin and a dashed line for placebo, with Atorvastatin consistently lower. Statistical values HR=0.64 and p=0.0005 are included.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph illustrating cumulative hazard (%) over time to first primary endpoint through four years of follow-up. Two lines compare placebo (dashed line) and atorvastatin (solid line), showing lower cumulative hazard with atorvastatin. The graph includes a hazard ratio (HR) 0.63 with confidence interval (0.48–0.83) and p-value 0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line chart depicting the percentage of subjects experiencing a major cardiovascular event over a five-year period, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The chart illustrates a lower event rate for the 80 mg dose compared to the 10 mg dose.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium depicting the molecular arrangement including phenyl rings, fluorine atom, hydroxyl groups, and calcium ion complex as shown in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.